NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis
Open Access
- 15 July 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (14) , 3466
Abstract
Lupus nephritis (LN) is a kidney inflammatory disease caused by systemic lupus erythematosus (SLE). NLRP3 inflammasome activation is implicated in LN pathogenesis, suggesting its potential targets for LN treatment. Melatonin, an endogenous indoleamine, is considered an important multitasking molecule that has been reported to have anti-inflammatory effects by inhibiting nuclear factor-kappa B (NF-κB)-mediated inflammatory responses in vivo. This molecule has also protective effects against the activation of the inflammasomes and, in particular, the NLRP3 inflammasome. Thus, this work evaluated the effect of melatonin on morphological alteration and NLRP3 inflammasome activation in LN pristane mouse models. To evaluate the melatonin effects in these mice, we studied the renal cytoarchitecture by means of morphological analyses and immunohistochemical expression of specific markers related to oxidative stress, inflammation and inflammasome activation. Our results showed that melatonin attenuates pristane-induced LN through restoring of morphology and attenuation of oxidative stress and inflammation through a pathway that inhibited activation of NLRP3 inflammasome signaling. Our data clearly demonstrate that melatonin has protective activity on lupus nephritis in these mice that is highly associated with its effect on enhancing the Nrf2 antioxidant signaling pathway and decreasing renal NLRP3 inflammasome activation.Keywords
This publication has 52 references indexed in Scilit:
- Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patientsImmunology Letters, 2019
- Melatonin attenuates airway inflammation via SIRT1 dependent inhibition of NLRP3 inflammasome and IL-1β in rats with COPDInternational Immunopharmacology, 2018
- Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injuryBehavioural Brain Research, 2018
- Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritisClinical Immunology, 2017
- Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus NephritisArthritis & Rheumatology, 2017
- Novel insights into the pathophysiology and clinical aspects of diabetic nephropathyReviews in Endocrine and Metabolic Disorders, 2017
- Salvianolic acid A alleviates renal injury in systemic lupus erythematosus induced by pristane in BALB/c miceActa Pharmaceutica Sinica B, 2017
- The Safety of Melatonin in HumansClinical Drug Investigation, 2015
- Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalinClinical Immunology, 2014
- Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disordersCellular Signalling, 2013